# Comparison of the Amplatzer Amulet Versus LAmbre Device for Left Atrial Appendage Closure

Study · id `cardio:ct-nct07260474` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07260474](<https://clinicaltrials.gov/study/NCT07260474>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07260474

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT07260474. Randomized; no masking; primary purpose treatment. Start 2024-05-05 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT07260474, source copy `cardio:ctgov-nct07260474-2026-10-07`, retrieved 2026-10-26)
- Started: 2024-05-05 (actual) (ClinicalTrials.gov record NCT07260474, source copy `cardio:ctgov-nct07260474-2026-10-07`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT07260474, source copy `cardio:ctgov-nct07260474-2026-10-07`, retrieved 2026-10-26)
- Completion: 2027-01-31 (anticipated) (ClinicalTrials.gov record NCT07260474, source copy `cardio:ctgov-nct07260474-2026-10-07`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT07260474, source copy `cardio:ctgov-nct07260474-2026-10-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07260474-2026-10-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of the Amplatzer Amulet Versus LAmbre Device for Left Atrial Appendage Closure
- Acronym: CALAMBRE
- Condition: Coronary Artery Disease
- Intervention (Device): Patients implanted with Amplatzer Amulet™
- Intervention (Device): Patients implanted with LAmbre™
- Lead sponsor: Fundación EPIC
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Fundación EPIC (`cardio:org-fundacion-epic`)

## Provenance

Content hash: f73950c9fa2040f9c398fb1b543972e8174977e989bd67388f2a56eddf44ad17
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
